BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Clinical Outcome
326 results:

  • 1. Spreading Through Air Spaces And Thinking About Lung Metastases.
    M Castro P; Rei J; Silva C; Miranda J; Guerra M
    Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with clinical outcomes of Guillain-Barre Syndrome Variants.
    Bano S; Nawaz A; Nasim A; Numan A; Zahid M
    J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.
    Numakura K; Igarashi R; Takahashi M; Nara T; Kanda S; Saito M; Narita S; Inoue T; Niioka T; Miura M; Habuchi T
    Cancer Biol Ther; 2024 Dec; 25(1):2312602. PubMed ID: 38327067
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
    Almutairi F; Xu B
    Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characteristics and clinical outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
    Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
    J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
    Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
    PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
    Milane LS; Dolare S; Ren G; Amiji M
    J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [clinical outcome of Surgical Resection for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus].
    Nakanishi H; Ohba K; Nakamura Y; Yasuda T; Mitsunari K; Matsuo T; Mochizuki Y; Miyata Y
    Hinyokika Kiyo; 2023 Aug; 69(8):207-214. PubMed ID: 37667597
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab.
    Matsumura S; Kato T; Kujime Y; Kitakaze H; Nakano K; Hongo S; Yoshioka I; Okumi M; Nonomura N; Takada S
    BMC Urol; 2023 Jun; 23(1):107. PubMed ID: 37301837
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development of an Immune Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Tumor Microenvironment.
    Wang M; Song Q; Song Z; Xie Y
    Horm Metab Res; 2023 Jun; 55(6):402-412. PubMed ID: 37192644
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of clinical Trials: A Real-World Retrospective Multi-Institutional Study.
    Ishihara H; Nemoto Y; Nakamura K; Tachibana H; Ikeda T; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Shimmura H; Hashimoto Y; Kondo T; Takagi T
    Target Oncol; 2023 Mar; 18(2):209-220. PubMed ID: 36941516
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
    Konaté MM; Li MC; McShane LM; Zhao Y
    Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
    Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Factors affecting prognosis of the patients with severe hyponatremia.
    Turkmen E; Karatas A; Altindal M
    Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways.
    Qi J; Shi Y; Tan Y; Zhang Q; Zhang J; Wang J; Huang C; Ci W
    Clin Epigenetics; 2022 Sep; 14(1):117. PubMed ID: 36127710
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
    Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
    [No Abstract]    [Full Text] [Related]  

  • 18. Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.
    Vibert R; Lahlou-Laforêt K; Samadi M; Krivosic V; Blanc T; Amar L; Burnichon N; Abadie C; Richard S; Gimenez-Roqueplo AP
    Eur J Hum Genet; 2022 Oct; 30(10):1171-1177. PubMed ID: 35918537
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oncological outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.
    Pignot G; Thiery-Vuillemin A; Albigès L; Walz J; Lang H; Balssa L; Parier B; Geoffrois L; Bensalah K; Schlürmann F; Ladoire S; Bigot P; Borchiellini D; Cassuto O; Thibault C; Ingels A; Saldana V; Roubaud G; Bernhard JC; Gravis G; Barthélémy P
    Eur Urol Oncol; 2022 Oct; 5(5):577-584. PubMed ID: 35853818
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Malignancy Diseases in kidney Transplantation, clinical outcomes, Patient, and Allograft Survival: A Case-Control Study.
    Pinto-Filho VA; Nascimento E; Cunha APL; Assis BPS; Lasmar MF; Vianna HR; Fabreti-Oliveira RA
    Transplant Proc; 2022 Jun; 54(5):1253-1261. PubMed ID: 35750515
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.